Indian pharma business to hit $57 billion by FY25
New Delhi: Home pharmaceutical business will seemingly hit $57 billion by FY25, together with enlargement in working margins by 100-150 ...
New Delhi: Home pharmaceutical business will seemingly hit $57 billion by FY25, together with enlargement in working margins by 100-150 ...
Glenmark Prescription drugs Ltd is contemplating promoting a majority stake in Glenmark Life Sciences to pare debt, stated two individuals ...
The federal government has prolonged the final date for purposes for manufacturing Lively Prescription drugs Elements (APIs) beneath the PLI ...
[mc4wp_form id=”158″]
© 2021 Success News - Developed by Sawah Web.
© 2021 Success News - Developed by Sawah Web.